POZEN INC /NC
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5M | $1.4M | $1.3M | $87.0M | $68.5M | $32.2M |
| Operating income | — | — | — | — | — | — |
| Net income | $2.9M | −$5.8M | −$25.3M | $42.3M | $23.1M | −$6.9M |
| Total assets | $50.5M | $35.3M | $89.6M | $121.6M | $69.7M | — |
| Total liabilities | — | — | — | $16.1M | $9.1M | — |
| Equity | $46.7M | $17.8M | $84.1M | $105.5M | $60.6M | $33.8M |
| EPS (diluted) | $0.09 | $-0.55 | $-0.84 | $1.40 | $0.76 | $-0.23 |
| Shares out. | 30.8M | 30.7M | 30.0M | 30.0M | 29.9M | 29.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- —
- Net margin
- 38.5%
- Return on equity
- 6.2%
- Return on assets
- 5.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.52
- Revenue growth (YoY)
- 433.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Accruals / assets
- 5.0%moderate
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 good- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Par Investment Partners Lp10% owner | Feb 5, 2016 | J | 3.9M | — |
| Kirsch Arthur SDirector | Jan 20, 2016 | Option exercise | 6,107 | $5.40 |
| Hodges William LOfficer — Chief Financial Officer | Dec 31, 2015 | Tax withholding | 2,948 | $6.83 |
| Mcnamara Dennis LOfficer — SVP & Chief Business Officer | Dec 31, 2015 | Tax withholding | 2,948 | $6.83 |
| Fort John G.Officer — Chief Medical Officer | Dec 31, 2015 | Tax withholding | 2,948 | $6.83 |
| Thomas Gilda MarieOfficer — Sr, VP, Gen Cnsl & Secretary | Dec 31, 2015 | Tax withholding | 2,948 | $6.83 |
| Barnhardt John EOfficer — VP, Finance and Administration | Dec 31, 2015 | Tax withholding | 1,474 | $6.83 |
| Tursi James PatrickOfficer — Chief Medical Officer | Oct 1, 2015 | Grant | 29,137 | $0.00 |
| Plachetka John R10% owner | Dec 3, 2015 | Sell | 23,479 | $8.14 |
| Plachetka John R10% owner | Nov 30, 2015 | Tax withholding | 297,837 | $7.59 |
| Plachetka John R10% owner | Nov 19, 2015 | Gift | 148,000 | $0.00 |
| Plachetka John R10% owner | Nov 13, 2015 | Sell | 150,000 | $7.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Amended charter or bylawsFeb 5, 2016
- Shareholder voteFeb 2, 2016
- Director / officer change · Other material eventDec 28, 2015
- Other material eventDec 14, 2015
- Entered a material agreement · Other material eventDec 8, 2015
- Other material eventNov 23, 2015
- Results of operationsNov 9, 2015
- Other material eventNov 6, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.